MIPI, AAPL, MSFT, FAST, CPRX, TLB, BGNN, CCTR, FNXC, ZVTK

Whether driven by news, chart or promotions, stocks will move…like these stocks.  These stocks showed up on my radar screen and I think are worthy of attention.  They are a mix of large cap, small cap and penny stocks   My comments are highlighted by the quotation marks and I usually only comment on stocks under $5.

Keep in mind that blogs are only part of what I do.  I send out periodic alerts on micro cap and penny stocks.   When you sign up for alerts from my site, you will receive stocks from 1 cent to several dollars.  My focus is finding small cap and micro cap stocks that look like they are ready to move.  Sign up today! A few weeks back you missed SECI which gained 170%. Lots of opportunity for gains on Investor Soup.

Molecular Insight Pharmaceuticals Inc. (NASDAQ: MIPI) $3.62 +141.33% MIPI shares surge on trial results (NASDAQ:MIPI), ($MIPI)

Boy, I love FDA approvals.  So does MIPI. Looking at a year-chart tells you that MIPI might have farther to run.  It is definitely not a short candidate….yet.

Apple Inc. (NASDAQ: AAPL) $241.97 -0.13% Apple upgrades its line of Macbook Pro laptops (NASDAQ:AAPL), ($AAPL)

Microsoft Corp. (NASDAQ: MSFT) $30.31 -0.03% Samsung Electronics announces plans to include Microsoft PlayReady technology in a broad range of its consumer devices (NASDAQ:MSFT), ($MSFT)

Fastenal Company (NASDAQ: FAST) $54.11 +4.26% Fastenal’s Q1 profit tops expectations (NASDAQ:FAST), ($FAST)

Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) $2.36 +24.87% CPRX enters into definitive agreement with the National Institute on Drug Abuse to conduct U.S. Phase II clinical trial for cocaine addiction (NASDAQ:CPRX), ($CPRX)

CPRX got a trifecta of good news with its news of the agreement with the NDA: financial assistance, government stamp of approval and logistical assistance.  If this drug gets approved (somewhere down the road) it will be the ONLY FDA-approved drug for cocaine addiction.  That is huge!

The Talbots Inc. (NYSE: TLB) $14.99 +4.17% TLB shares rising after earnings top estimates (NYSE:TLB), ($TLB)

B Green Innovations Inc. (OTC: BGNN) $0.0030 +57.89% B Green Innovations announces its environmentally conscious anti-vibration pad will debut on QVC TV (OTC:BGNN), ($BGNN)

An infomercial stock…yippee! Even though it is QVC, this company is very far from being a hit on QVC.

Expect this one to come crashing down and soon.  Their product is all hype and their website looks like my 10-yr. old nephew did it.  It is a sub-penny so all bets are off on this one.  Be very careful with BGNN.

China Crescent Enterprises Inc. (OTC: CCTR) $0.0210 +35.48% China Crescent Enterprises announces it will hold a CFO Web cast to review its year-to-date financial performance on April 16 (OTC:CCTR), ($CCTR)

All I can add to this is the old maxim:  “buy on rumor, sell on news”.  The expectation is often greater than the reality.  I expect CCTR to drop on April 16th.  Call me cynical, but I have seen it too many times.

Fonix Corp. (OTC: FNXC) $0.0005 +25% (OTC:FNXC), ($FNXC)

This is a sub, sub-penny and highly volatile. The news is that they have signed a partnership with China Crescent Enterprises (see above).  That could be huge…or maybe a precursor to being bought out by CCTR?  Take a quick peek at FNXC’s balance sheet and you will run screaming.

Zevotek Inc. (OTC: ZVTK) $0.0055 +27.91% Zevotek announces it has hired a retail sales agency to take them to national retailers

I must admit that I love ZVTK.  I have spoken with company management and they strike me as “stand up guys”.  They are trying to build a company around a novel product – an air ionizer/light bulb that plugs in to your light socket.  They are a one product company, but I love the buzz and hype that surrounds this stock.

The retail sales agreement announcement could be the “turning of a corner” that ZVTK needs to rescue it from sub-penny land.  Stay tuned.  I, for one, am rooting for them.

————————————————————————————————————————————————-

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.